Gene · 6582
Papers2,540
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
561 to 580 of 2,540
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Comparison of Renal Function Biomarkers of Serum Creatinine and Cystatin C in HIV-Infected People on Dolutegravir-Containing Therapy. | Infect Drug Resist | 2022 | 35422637 | PubTator, text mining | PubMed |
| A Pharmacokinetic Bioequivalence Study Comparing Different-Strength and -Size Capsules of Isavuconazonium Sulfate in Healthy Japanese Subjects. | Clin Pharmacol Drug Dev | 2022 | 35403832 | PubTator, text mining | PubMed |
| Emerging early diagnostic methods for acute kidney injury. | Theranostics | 2022 | 35401836 | PubTator, text mining | PubMed |
| Regulation of Drug Transport Proteins-From Mechanisms to Clinical Impact: A White Paper on Behalf of the International Transporter Consortium. | Clin Pharmacol Ther | 2022 | 35390174 | PubTator, text mining | PubMed |
| Screening of commonly prescribed drugs for effects on the CAT1-mediated transport of L-arginine and arginine derivatives. | Amino Acids | 2022 | 35377022 | PubTator, text mining | PubMed |
| Ifosfamide as a Cause of Fanconi Syndrome. | Cureus | 2022 | 35371860 | PubTator, text mining | PubMed |
| Clinical Aspects of Drug-Drug Interaction and Drug Nephrotoxicity at Renal Organic Cation Transporters 2 (OCT2) and Multidrug and Toxin Exclusion 1, and 2-K (MATE1/MATE2-K). | Biol Pharm Bull | 2022 | 35370262 | PubTator, text mining | PubMed |
| Expression status of p53 and organic cation transporter 1 is correlated with poor response to preoperative chemotherapy in esophageal squamous cell carcinoma. | World J Surg Oncol | 2022 | 35365176 | PubTator, text mining | PubMed |
| Evaluation of the Effect of Abrocitinib on Drug Transporters by Integrated Use of Probe Drugs and Endogenous Biomarkers. | Clin Pharmacol Ther | 2022 | 35344588 | PubTator, text mining | PubMed |
| What If Not All Metabolites from the Uremic Toxin Generating Pathways Are Toxic? A Hypothesis. | Toxins (Basel) | 2022 | 35324718 | PubTator, text mining | PubMed |
| The Interplay between Uremic Toxins and Albumin, Membrane Transporters and Drug Interaction. | Toxins (Basel) | 2022 | 35324674 | PubTator, text mining | PubMed |
| Interaction of Human Serum Albumin with Uremic Toxins: The Need of New Strategies Aiming at Uremic Toxins Removal. | Membranes (Basel) | 2022 | 35323736 | PubTator, text mining | PubMed |
| Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach. | PLoS Negl Trop Dis | 2022 | 35312681 | PubTator, text mining | PubMed |
| Localization of Xenobiotic Transporters Expressed at the Human Blood-Testis Barrier. | Drug Metab Dispos | 2022 | 35307651 | Swiss-Prot, curated | PubMed |
| Deoxynivalenol triggers porcine intestinal tight junction disorder through hijacking SLC5A1 and PGC1α-mediated mitochondrial function. | Food Chem Toxicol | 2022 | 35307453 | PubTator, text mining | PubMed |
| Diamine oxidase knockout mice are not hypersensitive to orally or subcutaneously administered histamine. | Inflamm Res | 2022 | 35303133 | PubTator, text mining | PubMed |
| A Computational Text Mining-Guided Meta-Analysis Approach to Identify Potential Xerostomia Drug Targets. | J Clin Med | 2022 | 35268532 | PubTator, text mining | PubMed |
| Metformin Intervention-A Panacea for Cancer Treatment? | Cancers (Basel) | 2022 | 35267644 | PubTator, text mining | PubMed |
| Clinicopathologic Features of Acute Kidney Injury Associated With CDK4/6 Inhibitors. | Kidney Int Rep | 2022 | 35257075 | PubTator, text mining | PubMed |
| Impact of Pals1 on Expression and Localization of Transporters Belonging to the Solute Carrier Family. | Front Mol Biosci | 2022 | 35252349 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6582/papers?page=29